SpringWorks Therapeutics’ $316.25 Million Underwritten Common Stock Offering

Goodwin advised SpringWorks Therapeutics, Inc. on the offering. American precision medicine company SpringWorks Therapeutics (Nasdaq: SWTX) has closed a public offering of 10,905,171 shares of its common…